Revising rapid-onset dystonia–parkinsonism: Broadening indications for ATP1A3 testing

Ihtsham U. Haq, Beverly M. Snively, Kathleen J. Sweadner, Cynthia K. Suerken, Jared F. Cook, Laurie J. Ozelius, Charlotte Miller, William V. McCall, Christopher T. Whitlow, Allison Brashear

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Objectives: Rapid-onset dystonia–parkinsonism (RDP) is caused by mutations in the ATP1A3 gene, which codes for the α-3 subunit of the Na+/K+ ATPase. It has been characterized by rapid-onset bulbar dysfunction, limb dystonia, bradykinesia, and a rostrocaudal spatial gradient of expression, usually after a physiologic trigger. We reexamined whether these features were in fact characteristic. Methods: We characterized phenotypic variation within a cohort of 50 ATP1A3 mutation-positive individuals (carriers) and 44 mutation-negative family members (noncarriers). Potential participants were gathered through referral for clinical suspicion of RDP or alternating hemiplegia of childhood. Inclusion criteria were having a ATP1A3 mutation or being a family member of such an individual. Results: We found RDP is underdiagnosed if only “characteristic” patients are tested. Rapid onset and bulbar predominance were not universally present in carriers. Among those with at least mild symptoms of dystonia, rostrocaudal severity gradient was rare (7%). Symptoms began focally but progressed to be generalized (51%) or multifocal (49%). Arm (41%) onset was most common. Arms and voice were typically most severely affected (48% and 44%, respectively). Triggers preceded onset in 77% of the participants. Rapid onset, dystonia, parkinsonism, bulbar symptoms, headaches, seizures, frontal impairment, and a history of mood disorder and a history of psychosis were more common in carriers. Approximately half of the proband mutations occurred de novo (56%). Conclusions: Our findings suggest that patients should not be excluded from ATP1A3 testing because of slow onset, limb onset, absent family history, or onset in middle adulthood. RDP should be strongly considered in the differential for any bulbar dystonia.

Original languageEnglish (US)
Pages (from-to)1528-1536
Number of pages9
JournalMovement Disorders
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2019
Externally publishedYes

Fingerprint

Dystonia
Mutation
Arm
Hypokinesia
Mood Disorders
Psychotic Disorders
Headache
Seizures
Referral and Consultation
Extremities
Genes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Haq, I. U., Snively, B. M., Sweadner, K. J., Suerken, C. K., Cook, J. F., Ozelius, L. J., ... Brashear, A. (2019). Revising rapid-onset dystonia–parkinsonism: Broadening indications for ATP1A3 testing. Movement Disorders, 34(10), 1528-1536. https://doi.org/10.1002/mds.27801

Revising rapid-onset dystonia–parkinsonism : Broadening indications for ATP1A3 testing. / Haq, Ihtsham U.; Snively, Beverly M.; Sweadner, Kathleen J.; Suerken, Cynthia K.; Cook, Jared F.; Ozelius, Laurie J.; Miller, Charlotte; McCall, William V.; Whitlow, Christopher T.; Brashear, Allison.

In: Movement Disorders, Vol. 34, No. 10, 01.10.2019, p. 1528-1536.

Research output: Contribution to journalArticle

Haq, IU, Snively, BM, Sweadner, KJ, Suerken, CK, Cook, JF, Ozelius, LJ, Miller, C, McCall, WV, Whitlow, CT & Brashear, A 2019, 'Revising rapid-onset dystonia–parkinsonism: Broadening indications for ATP1A3 testing', Movement Disorders, vol. 34, no. 10, pp. 1528-1536. https://doi.org/10.1002/mds.27801
Haq IU, Snively BM, Sweadner KJ, Suerken CK, Cook JF, Ozelius LJ et al. Revising rapid-onset dystonia–parkinsonism: Broadening indications for ATP1A3 testing. Movement Disorders. 2019 Oct 1;34(10):1528-1536. https://doi.org/10.1002/mds.27801
Haq, Ihtsham U. ; Snively, Beverly M. ; Sweadner, Kathleen J. ; Suerken, Cynthia K. ; Cook, Jared F. ; Ozelius, Laurie J. ; Miller, Charlotte ; McCall, William V. ; Whitlow, Christopher T. ; Brashear, Allison. / Revising rapid-onset dystonia–parkinsonism : Broadening indications for ATP1A3 testing. In: Movement Disorders. 2019 ; Vol. 34, No. 10. pp. 1528-1536.
@article{45fbaf49e68648a08a04504b557c610f,
title = "Revising rapid-onset dystonia–parkinsonism: Broadening indications for ATP1A3 testing",
abstract = "Background and Objectives: Rapid-onset dystonia–parkinsonism (RDP) is caused by mutations in the ATP1A3 gene, which codes for the α-3 subunit of the Na+/K+ ATPase. It has been characterized by rapid-onset bulbar dysfunction, limb dystonia, bradykinesia, and a rostrocaudal spatial gradient of expression, usually after a physiologic trigger. We reexamined whether these features were in fact characteristic. Methods: We characterized phenotypic variation within a cohort of 50 ATP1A3 mutation-positive individuals (carriers) and 44 mutation-negative family members (noncarriers). Potential participants were gathered through referral for clinical suspicion of RDP or alternating hemiplegia of childhood. Inclusion criteria were having a ATP1A3 mutation or being a family member of such an individual. Results: We found RDP is underdiagnosed if only “characteristic” patients are tested. Rapid onset and bulbar predominance were not universally present in carriers. Among those with at least mild symptoms of dystonia, rostrocaudal severity gradient was rare (7{\%}). Symptoms began focally but progressed to be generalized (51{\%}) or multifocal (49{\%}). Arm (41{\%}) onset was most common. Arms and voice were typically most severely affected (48{\%} and 44{\%}, respectively). Triggers preceded onset in 77{\%} of the participants. Rapid onset, dystonia, parkinsonism, bulbar symptoms, headaches, seizures, frontal impairment, and a history of mood disorder and a history of psychosis were more common in carriers. Approximately half of the proband mutations occurred de novo (56{\%}). Conclusions: Our findings suggest that patients should not be excluded from ATP1A3 testing because of slow onset, limb onset, absent family history, or onset in middle adulthood. RDP should be strongly considered in the differential for any bulbar dystonia.",
author = "Haq, {Ihtsham U.} and Snively, {Beverly M.} and Sweadner, {Kathleen J.} and Suerken, {Cynthia K.} and Cook, {Jared F.} and Ozelius, {Laurie J.} and Charlotte Miller and McCall, {William V.} and Whitlow, {Christopher T.} and Allison Brashear",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/mds.27801",
language = "English (US)",
volume = "34",
pages = "1528--1536",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Revising rapid-onset dystonia–parkinsonism

T2 - Broadening indications for ATP1A3 testing

AU - Haq, Ihtsham U.

AU - Snively, Beverly M.

AU - Sweadner, Kathleen J.

AU - Suerken, Cynthia K.

AU - Cook, Jared F.

AU - Ozelius, Laurie J.

AU - Miller, Charlotte

AU - McCall, William V.

AU - Whitlow, Christopher T.

AU - Brashear, Allison

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Background and Objectives: Rapid-onset dystonia–parkinsonism (RDP) is caused by mutations in the ATP1A3 gene, which codes for the α-3 subunit of the Na+/K+ ATPase. It has been characterized by rapid-onset bulbar dysfunction, limb dystonia, bradykinesia, and a rostrocaudal spatial gradient of expression, usually after a physiologic trigger. We reexamined whether these features were in fact characteristic. Methods: We characterized phenotypic variation within a cohort of 50 ATP1A3 mutation-positive individuals (carriers) and 44 mutation-negative family members (noncarriers). Potential participants were gathered through referral for clinical suspicion of RDP or alternating hemiplegia of childhood. Inclusion criteria were having a ATP1A3 mutation or being a family member of such an individual. Results: We found RDP is underdiagnosed if only “characteristic” patients are tested. Rapid onset and bulbar predominance were not universally present in carriers. Among those with at least mild symptoms of dystonia, rostrocaudal severity gradient was rare (7%). Symptoms began focally but progressed to be generalized (51%) or multifocal (49%). Arm (41%) onset was most common. Arms and voice were typically most severely affected (48% and 44%, respectively). Triggers preceded onset in 77% of the participants. Rapid onset, dystonia, parkinsonism, bulbar symptoms, headaches, seizures, frontal impairment, and a history of mood disorder and a history of psychosis were more common in carriers. Approximately half of the proband mutations occurred de novo (56%). Conclusions: Our findings suggest that patients should not be excluded from ATP1A3 testing because of slow onset, limb onset, absent family history, or onset in middle adulthood. RDP should be strongly considered in the differential for any bulbar dystonia.

AB - Background and Objectives: Rapid-onset dystonia–parkinsonism (RDP) is caused by mutations in the ATP1A3 gene, which codes for the α-3 subunit of the Na+/K+ ATPase. It has been characterized by rapid-onset bulbar dysfunction, limb dystonia, bradykinesia, and a rostrocaudal spatial gradient of expression, usually after a physiologic trigger. We reexamined whether these features were in fact characteristic. Methods: We characterized phenotypic variation within a cohort of 50 ATP1A3 mutation-positive individuals (carriers) and 44 mutation-negative family members (noncarriers). Potential participants were gathered through referral for clinical suspicion of RDP or alternating hemiplegia of childhood. Inclusion criteria were having a ATP1A3 mutation or being a family member of such an individual. Results: We found RDP is underdiagnosed if only “characteristic” patients are tested. Rapid onset and bulbar predominance were not universally present in carriers. Among those with at least mild symptoms of dystonia, rostrocaudal severity gradient was rare (7%). Symptoms began focally but progressed to be generalized (51%) or multifocal (49%). Arm (41%) onset was most common. Arms and voice were typically most severely affected (48% and 44%, respectively). Triggers preceded onset in 77% of the participants. Rapid onset, dystonia, parkinsonism, bulbar symptoms, headaches, seizures, frontal impairment, and a history of mood disorder and a history of psychosis were more common in carriers. Approximately half of the proband mutations occurred de novo (56%). Conclusions: Our findings suggest that patients should not be excluded from ATP1A3 testing because of slow onset, limb onset, absent family history, or onset in middle adulthood. RDP should be strongly considered in the differential for any bulbar dystonia.

UR - http://www.scopus.com/inward/record.url?scp=85070338698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070338698&partnerID=8YFLogxK

U2 - 10.1002/mds.27801

DO - 10.1002/mds.27801

M3 - Article

C2 - 31361359

AN - SCOPUS:85070338698

VL - 34

SP - 1528

EP - 1536

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 10

ER -